Skip to main content
Ann Punnoose, MD, Pediatric Cardiology, Silver Spring, MD

AnnRajuPunnooseMD

Pediatric Cardiology Silver Spring, MD

Pediatric Heart Failure and Heart Transplantation

Medical Officer, Center for Drug Evaluation and Research at the Food and Drug Administration

Dr. Punnoose is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Punnoose's full profile

Already have an account?

  • Office

    10903 New Hampshire Avenue
    Silver Spring, MD 20993

Education & Training

  • McGaw Medical Center of Northwestern University/Ann & Robert H Lurie Children's Hospital of Chicago
    McGaw Medical Center of Northwestern University/Ann & Robert H Lurie Children's Hospital of ChicagoFellowship, Senior Fellow, Pediatric Heart Failure & Transplant , 2015 - 2016
  • Children's National Hospital/George Washington University
    Children's National Hospital/George Washington UniversityFellowship, Pediatric Cardiology, 2012 - 2015
  • Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical Center
    Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterResidency, Pediatrics, 2008 - 2011
  • Pennsylvania State University College of Medicine
    Pennsylvania State University College of MedicineClass of 2008

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 2012 - 2024
  • WI State Medical License
    WI State Medical License 2016 - 2021
  • IL State Medical License
    IL State Medical License 2015 - 2017
  • NY State Medical License
    NY State Medical License 2009 - 2012
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Cardiology

Publications & Presentations

PubMed

Press Mentions

  • 'Impossible' FDA Adcomm Ends in Favor of Stealth’s Ultra-Rare Disease Med
    'Impossible' FDA Adcomm Ends in Favor of Stealth’s Ultra-Rare Disease MedOctober 10th, 2024

Professional Memberships